Jessica Garcia
University of Texas Southwestern Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jessica Garcia as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:45 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT04690322 · POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement TherapiesUniversity of Texas Southwestern Medical Center · withdrawn · Hemophilia A, Factor VIII · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:45 UTC. The ranking covers the 200 most relevant of 457 PubMed records, and a shared surname and initials can bring in a namesake. All 457 on PubMed
- Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.N Engl J Med · 20202,533 citationsRCR 110.4
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.N Engl J Med · 20152,395 citationsRCR 78.3
- 2,107 citationsRCR 87.1
- 1,361 citationsRCR 52.9
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial.J Clin Oncol · 2018877 citationsRCR 32.8
- Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma.N Engl J Med · 2013452 citationsRCR 11.9
- 436 citationsRCR 41.2
- Endogenous circadian system and circadian misalignment impact glucose tolerance via separate mechanisms in humans.Proc Natl Acad Sci U S A · 2015425 citationsRCR 16.1
- Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device.J Heart Lung Transplant · 2015328 citationsRCR 13.3
- 308 citationsRCR 15.8